• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病患者的出血性胃溃疡经英夫利昔单抗治疗成功。

Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab.

作者信息

Fujiwara Shun, Kawamoto Ami, Motobayashi Maiko, Hibiya Shuji, Takenaka Kento, Shimizu Hiromichi, Saito Eiko, Fujii Toshimitsu, Nagahori Masakazu, Kawata Daisuke, Umezawa Natsuka, Hosoya Tadashi, Yasuda Shinsuke, Ohtsuka Kazuo, Okamoto Ryuichi

机构信息

Department of Gastroenterology and Hepatology Tokyo Medical and Dental University Tokyo Japan.

Endoscopic Unit Tokyo Medical and Dental University Hospital Tokyo Japan.

出版信息

DEN Open. 2022 Dec 15;3(1):e196. doi: 10.1002/deo2.196. eCollection 2023 Apr.

DOI:10.1002/deo2.196
PMID:36540902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9755104/
Abstract

Behcet's disease (BD) is a multisystem immune-mediated inflammatory disorder that occasionally involves the gastrointestinal tract. Reports on gastrointestinal involvement of BD are relatively rare, of which gastroduodenal involvement is particularly rare. Endoscopic features of gastroduodenal lesions are unknown, and treatment strategies have not been established. In this report, we present the case of a 72-year-old female with gastrointestinal BD who presented with extensive gastroduodenal ulcers and hematemesis that were resistant to colchicine and corticosteroid treatment, which were subsequently successfully treated with infliximab. We also review the current literature on the gastroduodenal involvement of BD. Although rare, the case highlights the importance of being aware of upper gastrointestinal manifestations of BD, as well as demonstrating the potential of infliximab to treat corticosteroid-resistant cases.

摘要

白塞病(BD)是一种多系统免疫介导的炎症性疾病,偶尔累及胃肠道。关于BD胃肠道受累的报道相对较少,其中胃十二指肠受累尤为罕见。胃十二指肠病变的内镜特征尚不清楚,治疗策略也未确立。在本报告中,我们介绍了一例72岁女性胃肠道BD患者,该患者出现广泛的胃十二指肠溃疡和呕血,对秋水仙碱和皮质类固醇治疗耐药,随后使用英夫利昔单抗成功治疗。我们还回顾了关于BD胃十二指肠受累的当前文献。尽管罕见,但该病例凸显了认识BD上消化道表现的重要性,同时也证明了英夫利昔单抗治疗皮质类固醇耐药病例的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a673/9755104/68beba3b80e5/DEO2-3-e196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a673/9755104/a6091f53651c/DEO2-3-e196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a673/9755104/0f48bece4480/DEO2-3-e196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a673/9755104/68beba3b80e5/DEO2-3-e196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a673/9755104/a6091f53651c/DEO2-3-e196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a673/9755104/0f48bece4480/DEO2-3-e196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a673/9755104/68beba3b80e5/DEO2-3-e196-g001.jpg

相似文献

1
Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab.白塞病患者的出血性胃溃疡经英夫利昔单抗治疗成功。
DEN Open. 2022 Dec 15;3(1):e196. doi: 10.1002/deo2.196. eCollection 2023 Apr.
2
High frequency of unusual gastric/duodenal ulcers in patients with Behçet's disease in Taiwan: a possible correlation of MHC molecules with the development of gastric/duodenal ulcers.台湾白塞病患者中不寻常胃/十二指肠溃疡的高发生率:MHC分子与胃/十二指肠溃疡发生之间的可能关联
Clin Rheumatol. 2005 Sep;24(5):516-20. doi: 10.1007/s10067-005-1083-z. Epub 2005 Apr 23.
3
Intestinal Behçet's and suspected intestinal Behçet's disease: a report of four surgical cases.肠道白塞病及疑似肠道白塞病:4例手术病例报告
Surg Case Rep. 2024 Jan 2;10(1):3. doi: 10.1186/s40792-023-01798-2.
4
Chronic diarrhea as a presentation of Behçet's disease.以慢性腹泻为表现的白塞病
Clin Case Rep. 2023 May 18;11(5):e7359. doi: 10.1002/ccr3.7359. eCollection 2023 May.
5
A rare case of Behcet's disease in Nepal: multisystem manifestations and diagnostic challenges.尼泊尔一例罕见的白塞病病例:多系统表现及诊断挑战
Ann Med Surg (Lond). 2023 Sep 5;85(10):5259-5262. doi: 10.1097/MS9.0000000000001279. eCollection 2023 Oct.
6
Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.英夫利昔单抗成功治疗白塞病危及生命的肠道溃疡:英夫利昔单抗使白塞病溃疡迅速愈合。
Clin Rheumatol. 2007 Aug;26(8):1383-5. doi: 10.1007/s10067-006-0410-3. Epub 2006 Oct 13.
7
Adalimumab in the management of Behçet's disease.阿达木单抗在白塞病治疗中的应用
Ther Clin Risk Manag. 2015 Apr 13;11:611-9. doi: 10.2147/TCRM.S56163. eCollection 2015.
8
A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years.1例采用英夫利昔单抗单药治疗的肠道白塞病患者成功维持临床缓解和完全黏膜愈合达6年。
Intern Med. 2012;51(16):2125-9. doi: 10.2169/internalmedicine.51.8005. Epub 2012 Aug 15.
9
Case Report: A Case of Intestinal Behçet's Disease Exhibiting Enhanced Expression of IL-6 and Forkhead Box P3 mRNA After Treatment With Infliximab.病例报告:1例肠白塞病在用英夫利昔单抗治疗后白细胞介素-6和叉头框蛋白P3信使核糖核酸表达增强
Front Med (Lausanne). 2021 May 14;8:679237. doi: 10.3389/fmed.2021.679237. eCollection 2021.
10
New insight into the features of Behçet's disease with gastrointestinal ulcer: a cross-sectional observational study.对伴有胃肠道溃疡的白塞病特征的新认识:一项横断面观察性研究。
Orphanet J Rare Dis. 2021 Oct 21;16(1):444. doi: 10.1186/s13023-021-02056-0.

本文引用的文献

1
New insight into the features of Behçet's disease with gastrointestinal ulcer: a cross-sectional observational study.对伴有胃肠道溃疡的白塞病特征的新认识:一项横断面观察性研究。
Orphanet J Rare Dis. 2021 Oct 21;16(1):444. doi: 10.1186/s13023-021-02056-0.
2
Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.临床聚类比例的变化促成了日本白塞病的表型演变。
Arthritis Res Ther. 2021 Feb 1;23(1):49. doi: 10.1186/s13075-020-02406-6.
3
Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.
早期联合免疫抑制治疗在老年克罗恩病患者中可能是有效且安全的:REACT 的事后分析。
Aliment Pharmacol Ther. 2019 May;49(9):1188-1194. doi: 10.1111/apt.15214. Epub 2019 Mar 19.
4
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial.一项3期临床试验后的开放标签研究中阿达木单抗治疗肠道白塞病的长期安全性和疗效。
Intest Res. 2017 Jul;15(3):395-401. doi: 10.5217/ir.2017.15.3.395. Epub 2017 Jun 12.
5
Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.英夫利昔单抗治疗白塞病肠道、神经及血管受累:一项多中心、前瞻性、开放标签、单臂3期研究中的疗效、安全性及药代动力学
Medicine (Baltimore). 2016 Jun;95(24):e3863. doi: 10.1097/MD.0000000000003863.
6
Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome: A Strobe-Compliant Observational Study From a Dedicated Multidisciplinary Center.白塞病胃肠道受累的特征、治疗及长期预后:来自一个专业多学科中心的符合STROBE标准的观察性研究
Medicine (Baltimore). 2016 Apr;95(16):e3348. doi: 10.1097/MD.0000000000003348.
7
Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study.英夫利昔单抗治疗肠道贝赫切特病的疗效:一项韩国多中心回顾性研究。
Inflamm Bowel Dis. 2013 Aug;19(9):1833-8. doi: 10.1097/MIB.0b013e31828f19c9.
8
High frequency of unusual gastric/duodenal ulcers in patients with Behçet's disease in Taiwan: a possible correlation of MHC molecules with the development of gastric/duodenal ulcers.台湾白塞病患者中不寻常胃/十二指肠溃疡的高发生率:MHC分子与胃/十二指肠溃疡发生之间的可能关联
Clin Rheumatol. 2005 Sep;24(5):516-20. doi: 10.1007/s10067-005-1083-z. Epub 2005 Apr 23.